| Disease ID | Disease name | Source of annotation with STAT1 | OMIM link | Number of associated genes | genes |
|---|---|---|---|---|---|
| 614892 | IMMUNODEFICIENCY 31A | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | STAT1 |
| PS114580 | FAMILIAL CANDIDIASIS | ClinVar, OMIM, HUMSAVAR | link to OMIM | 7 | TRAF3IP2, IL17RC, IL17RA, IL17F, CARD9, STAT1, CLEC7A |
| 613796 | IMMUNODEFICIENCY 31B | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | STAT1 |
Download the gene annotation in CSV format
| KEGG pathway | KEGG ID | KEGG IC |
|---|---|---|
| Pancreatic cancer | hsa05212 | 6.56 |
| Hepatitis C | hsa05160 | 5.68 |
| Inflammatory bowel disease (IBD) | hsa05321 | 6.43 |
| Toll-like receptor signaling pathway | hsa04620 | 6.0 |
| Pathways in cancer | hsa05200 | 3.98 |
| Jak-STAT signaling pathway | hsa04630 | 5.44 |
| Leishmaniasis | hsa05140 | 6.32 |
| Tuberculosis | hsa05152 | 5.17 |
| Herpes simplex infection | hsa05168 | 5.08 |
| Prolactin signaling pathway | hsa04917 | 6.6 |
| Osteoclast differentiation | hsa04380 | 5.64 |
| Influenza A | hsa05164 | 5.21 |
| Toxoplasmosis | hsa05145 | 5.71 |
| Thyroid hormone signaling pathway | hsa04919 | 5.82 |
| Chemokine signaling pathway | hsa04062 | 5.19 |
| Hepatitis B | hsa05161 | 5.52 |
| Measles | hsa05162 | 5.6 |
| REACTOME pathway | REACTOME ID | REACTOME IC |
|---|---|---|
| Signaling by Interleukins | R-HSA-449147 | 4.71 |
| Immune System | R-HSA-168256 | 2.37 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.83 |
| Regulation of IFNA signaling | R-HSA-912694 | 8.34 |
| Downstream signal transduction | R-HSA-186763 | 4.65 |
| Disease | R-HSA-1643685 | 3.33 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.4 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
| Interferon gamma signaling | R-HSA-877300 | 5.67 |
| Interferon Signaling | R-HSA-913531 | 4.95 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.12 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.49 |
| Diseases of signal transduction | R-HSA-5663202 | 4.89 |
| Signaling by FGFR1 fusion mutants | R-HSA-1839117 | 8.81 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.81 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.83 |
| Interleukin-6 signaling | R-HSA-1059683 | 9.52 |
| Regulation of IFNG signaling | R-HSA-877312 | 9.18 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.04 |
| Signaling by PDGF | R-HSA-186797 | 4.53 |
| Signal Transduction | R-HSA-162582 | 1.78 |
| GO term | GO ID | GO IC |
|---|---|---|
| cytokine receptor binding | GO:0005126 | 4.14 |
| enzyme binding | GO:0019899 | 2.27 |
| nucleic acid binding | GO:0003676 | 1.44 |
| RNA polymerase II regulatory region DNA binding | GO:0001012 | 3.36 |
| core promoter proximal region DNA binding | GO:0001159 | 3.82 |
| binding | GO:0005488 | 0.18 |
| signal transducer activity | GO:0004871 | 2.28 |
| DNA binding | GO:0003677 | 1.92 |
| RNA polymerase II core promoter proximal region sequence-specific DNA binding | GO:0000978 | 3.88 |
| heterocyclic compound binding | GO:1901363 | 1.06 |
| sequence-specific DNA binding | GO:0043565 | 2.79 |
| sequence-specific double-stranded DNA binding | GO:1990837 | 3.2 |
| identical protein binding | GO:0042802 | 2.63 |
| core promoter proximal region sequence-specific DNA binding | GO:0000987 | 3.83 |
| double-stranded DNA binding | GO:0003690 | 3.09 |
| transcription factor activity, RNA polymerase II core promoter sequence-specific | GO:0000983 | 7.1 |
| RNA polymerase II transcription factor activity, sequence-specific DNA binding | GO:0000981 | 3.29 |
| protein homodimerization activity | GO:0042803 | 3.16 |
| tumor necrosis factor receptor superfamily binding | GO:0032813 | 5.89 |
| regulatory region nucleic acid binding | GO:0001067 | 3.03 |
| tumor necrosis factor receptor binding | GO:0005164 | 6.3 |
| core promoter binding | GO:0001047 | 4.71 |
| core promoter sequence-specific DNA binding | GO:0001046 | 5.12 |
| protein dimerization activity | GO:0046983 | 2.72 |
| transcription regulatory region DNA binding | GO:0044212 | 3.03 |
| transcription factor activity, sequence-specific DNA binding | GO:0003700 | 2.65 |
| organic cyclic compound binding | GO:0097159 | 1.05 |
| transcription regulatory region sequence-specific DNA binding | GO:0000976 | 3.24 |
| RNA polymerase II regulatory region sequence-specific DNA binding | GO:0000977 | 3.37 |
| protein binding | GO:0005515 | 0.46 |
| regulatory region DNA binding | GO:0000975 | 3.03 |
| receptor binding | GO:0005102 | 2.43 |
| RNA polymerase II core promoter sequence-specific DNA binding | GO:0000979 | 5.77 |
| nucleic acid binding transcription factor activity | GO:0001071 | 2.65 |